CN107156409A - One kind reduction uric acid prevents antipodagric Synsepalum dulcuficum (Schum.) Daniell syrup and its production technology - Google Patents
One kind reduction uric acid prevents antipodagric Synsepalum dulcuficum (Schum.) Daniell syrup and its production technology Download PDFInfo
- Publication number
- CN107156409A CN107156409A CN201710287728.0A CN201710287728A CN107156409A CN 107156409 A CN107156409 A CN 107156409A CN 201710287728 A CN201710287728 A CN 201710287728A CN 107156409 A CN107156409 A CN 107156409A
- Authority
- CN
- China
- Prior art keywords
- schum
- daniell
- syrup
- synsepalum dulcuficum
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000631882 Synsepalum Species 0.000 title claims abstract description 56
- 239000006188 syrup Substances 0.000 title claims abstract description 31
- 235000020357 syrup Nutrition 0.000 title claims abstract description 31
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 title claims abstract description 20
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 title claims abstract description 19
- 229940116269 uric acid Drugs 0.000 title claims abstract description 19
- 230000009467 reduction Effects 0.000 title claims abstract description 11
- 238000005516 engineering process Methods 0.000 title abstract description 5
- 238000004519 manufacturing process Methods 0.000 title abstract description 4
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 244000248349 Citrus limon Species 0.000 claims abstract description 20
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 20
- 241000207199 Citrus Species 0.000 claims abstract description 17
- 235000020971 citrus fruits Nutrition 0.000 claims abstract description 17
- 239000011435 rock Substances 0.000 claims abstract description 15
- 238000009835 boiling Methods 0.000 claims abstract description 10
- 238000001816 cooling Methods 0.000 claims abstract description 9
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims description 4
- 235000012907 honey Nutrition 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 10
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- 201000005569 Gout Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- XXLFLUJXWKXUGS-UHFFFAOYSA-N 6-methoxyquinoline-4-carboxylic acid Chemical compound N1=CC=C(C(O)=O)C2=CC(OC)=CC=C21 XXLFLUJXWKXUGS-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 102000005666 Apolipoprotein A-I Human genes 0.000 description 1
- 108010059886 Apolipoprotein A-I Proteins 0.000 description 1
- 101710095342 Apolipoprotein B Proteins 0.000 description 1
- 102100040202 Apolipoprotein B-100 Human genes 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- -1 azo arsenic III Chemical compound 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000021433 fructose syrup Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- FAHBNUUHRFUEAI-UHFFFAOYSA-M hydroxidooxidoaluminium Chemical compound O[Al]=O FAHBNUUHRFUEAI-UHFFFAOYSA-M 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000001171 synovial bursa Anatomy 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Prevent antipodagric Synsepalum dulcuficum (Schum.) Daniell syrup and its production technology the invention discloses one kind reduction uric acid, wherein Synsepalum dulcuficum (Schum.) Daniell syrup includes the raw material of following parts by weight：80 130 parts of Synsepalum dulcuficum (Schum.) Daniell, 50 70 parts of rock sugar, 150 200 parts of Lemon fruit, 1 1.2 parts of Synsepalum dulcuficum (Schum.) Daniell leaf, 1 1.2 parts of lemonlike citrus leaf.Its technique comprises the following steps：S1. Synsepalum dulcuficum (Schum.) Daniell, rock sugar, Lemon fruit, Synsepalum dulcuficum (Schum.) Daniell leaf and lemonlike citrus leaf are proportionally weighed；S2. Synsepalum dulcuficum (Schum.) Daniell is enucleated, after Lemon fruit stoning peeling, Synsepalum dulcuficum (Schum.) Daniell, Lemon fruit, Synsepalum dulcuficum (Schum.) Daniell leaf, lemonlike citrus leaf and rock sugar is subjected to the broken the latter of mixing and crushed respectively, and most all raw material mixing at last；S3. mixed raw material 15h of boiling 5 at a temperature of 100 150 DEG C will be crushed, until the soft rotten formation syrup of raw material；S4. the syrup after boiling is cooled down, cool time is 2.5 3h；S5. the syrup after cooling is packaged.
Description
Technical field
Prevent antipodagric Synsepalum dulcuficum (Schum.) Daniell sugar the present invention relates to biological product technical field, more particularly to a kind of reduction uric acid
Slurry.
Background technology
Gout is a kind of because biosynthesis of purine is metabolized increase, and uric acid produces excessive or causes blood because uric acid excretion is bad
Middle uric acid rise, urate crystal is deposited in synovium of joint, synovial bursa, cartilage and its hetero-organization caused repeated relapsing inflammatory
Disease.Meat product easily causes purine intake excessively containing more in modern life material abundance, diet, so that body
The uric acid that intracellular metabolite is produced excessively causes gout.
The content of the invention
Uric acid, which can be reduced, it is an object of the invention to overcome the deficiencies of the prior art and provide one kind prevents that antipodagric honey draws holy
Fructose syrup.
In order to realize the above object the technical solution adopted in the present invention is：
One kind reduction uric acid prevents antipodagric Synsepalum dulcuficum (Schum.) Daniell syrup, includes the raw material of following parts by weight：80-130 parts of Synsepalum dulcuficum (Schum.) Daniell,
50-70 parts of rock sugar, 150-200 parts of Lemon fruit, 1-1.2 parts of Synsepalum dulcuficum (Schum.) Daniell leaf, 1-1.2 parts of lemonlike citrus leaf.
The present invention further simultaneously discloses the production technology that above-mentioned reduction uric acid prevents antipodagric Synsepalum dulcuficum (Schum.) Daniell syrup, including with
Lower step：
S1. Synsepalum dulcuficum (Schum.) Daniell, rock sugar, Lemon fruit, Synsepalum dulcuficum (Schum.) Daniell leaf and lemonlike citrus leaf are proportionally weighed；
S2. to Synsepalum dulcuficum (Schum.) Daniell be enucleated, Lemon fruit stoning peeling after, by Synsepalum dulcuficum (Schum.) Daniell, Lemon fruit, Synsepalum dulcuficum (Schum.) Daniell leaf, lemonlike citrus leaf with
And rock sugar carries out the broken the latter of mixing and crushed respectively, and most all raw material mixing at last；
S3. mixed raw material boiling 5-15h at a temperature of 100-150 DEG C will be crushed, until the soft rotten formation syrup of raw material；
S4. the syrup after boiling is cooled down, cool time is 2.5-3h；
S5. the syrup after cooling is packaged.
Preferably, the type of cooling in step S4 cools down for ice bath.
The beneficial effects of the invention are as follows：Include Synsepalum dulcuficum (Schum.) Daniell, honey in the Synsepalum dulcuficum (Schum.) Daniell syrup of the present invention, its raw material and draw holy
Fruit leaf, Lemon fruit and lemonlike citrus leaf.
Wherein its pulp of Synsepalum dulcuficum (Schum.) Daniell contains abundant peculiar glycoprotein, antioxidant superelevation amount, vitamin c.KI, wax fruit
Acid, butanedioic acid, oxalic acid etc..In addition, Synsepalum dulcuficum (Schum.) Daniell also has effects that reduction uric acid, blood fat, blood glucose and blood pressure.Take this hair
Bright Synsepalum dulcuficum (Schum.) Daniell syrup can dissolve the symptom of patient with gout.In addition, Synsepalum dulcuficum (Schum.) Daniell can also improve the local flavor of Limon pulp in itself,
Eliminate the tart flavour and bitter taste of lemon and allow lemon flavour to sweeten.And Synsepalum dulcuficum (Schum.) Daniell leaf contains the trace carbons such as sodium, potassium, calcium, magnesium
Element and natural sterol, are available for human body to supplement corresponding nutritional ingredient.
Lemon fruit rich in carbohydrate, calcium, phosphorus, iron, vitamin B1, vitamin B2, nicotinic acid, quininic acid, citric acid, malic acid,
Aurantiamarin, aurantiin, coumarin, a large amount potassium element and low amounts sodium element etc., it is highly beneficial to human body.In addition lemon is also rich in dimension
Raw element C and citrin, can strengthen blood vessel elasticity and toughness, can prevent and treat hypertension and myocardial infarction symptoms.Lemonlike citrus leaf has
The effect of having preventing phlegm from forming and stopping coughing, regulating qi-flowing for harmonizing stomach, antidiarrheal.It is usually used in cough and phlegm, stagnation of the circulation of vital energy abdominal distension, diarrhea.
Embodiment
Now claimed technical solution of the invention is described in further detail by following examples.
Embodiment one
Synsepalum dulcuficum (Schum.) Daniell syrup in the present embodiment includes the raw material of following parts by weight：80 parts of Synsepalum dulcuficum (Schum.) Daniell, 50 parts of rock sugar, Lemon fruit
150 parts, 1 part of Synsepalum dulcuficum (Schum.) Daniell leaf, 1 part of lemonlike citrus leaf.
Its preparation method comprises the following steps：
S1. Synsepalum dulcuficum (Schum.) Daniell, rock sugar, Lemon fruit, Synsepalum dulcuficum (Schum.) Daniell leaf and lemonlike citrus leaf are proportionally weighed；
S2. to Synsepalum dulcuficum (Schum.) Daniell be enucleated, Lemon fruit stoning peeling after, by Synsepalum dulcuficum (Schum.) Daniell, Lemon fruit, Synsepalum dulcuficum (Schum.) Daniell leaf, lemonlike citrus leaf with
And rock sugar carries out the broken the latter of mixing and crushed respectively, and most all raw material mixing at last；
S3. mixed raw material boiling 5-15h at a temperature of 100-150 DEG C will be crushed, until the soft rotten formation syrup of raw material；
S4. the syrup after boiling is subjected to ice bath cooling, cool time is 2.5-3h；
S5. the syrup after cooling is packaged.
Embodiment two
Synsepalum dulcuficum (Schum.) Daniell syrup in the present embodiment includes 70 parts of 130 parts of raw material Synsepalum dulcuficum (Schum.) Daniell, rock sugar, the Lemon fruit of following parts by weight
1200 parts, 1.2 parts of Synsepalum dulcuficum (Schum.) Daniell leaf, 1.2 parts of lemonlike citrus leaf.
Its preparation method comprises the following steps：
S1. Synsepalum dulcuficum (Schum.) Daniell, rock sugar, Lemon fruit, Synsepalum dulcuficum (Schum.) Daniell leaf and lemonlike citrus leaf are proportionally weighed；
S2. to Synsepalum dulcuficum (Schum.) Daniell be enucleated, Lemon fruit stoning peeling after, by Synsepalum dulcuficum (Schum.) Daniell, Lemon fruit, Synsepalum dulcuficum (Schum.) Daniell leaf, lemonlike citrus leaf with
And rock sugar carries out the broken the latter of mixing and crushed respectively, and most all raw material mixing at last；
S3. mixed raw material boiling 5-15h at a temperature of 100-150 DEG C will be crushed, until the soft rotten formation syrup of raw material；
S4. the syrup after boiling is subjected to ice bath cooling, cool time is 2.5-3h；
S5. the syrup after cooling is packaged.
The Synsepalum dulcuficum (Schum.) Daniell syrup a kind of to above-described embodiment carries out efficacy test, and tester's continuous two weeks takes one daily
Spoon（About 2-3 grams）The Synsepalum dulcuficum (Schum.) Daniell syrup of the present invention, the test result of every Serum Indexes is as follows before and after taking：
| Test event | Before taking | After taking | Experimental method |
| Urea | 5.34 mmol/L | 4.08 mmol/L | Enzyme coupling rate method |
| Creatinine | 84 μmol/L | 86 μmol/L | Enzyme process |
| Uric acid | 620 μmol/L | 530 μmol/L | Uric acid enzymic colorimetric |
| Calcium | 2.49 mmol/L | 2.41 mmol/L | The method of azo arsenic III |
| Phosphorus | 1.24 mmol/L | 0.94 mmol/L | Phosphorus aluminic acid ultraviolet method |
| T-CHOL | 7.05mmol/L | 6.55 mmol/L | Cholesterol oxidation method |
| Bladder chalone C | 0.92 mg/L | 0.85 mg/L | Colloid gold immune turbidimetry |
| Glucose | 5.24 mmol/L | 5.54 mmol/L | Hexokinase method |
| Triglycerides | 1.36 mmol/L | 1.30 mmol/L | Enzyme process |
| Apolipoprotein A1 | 2.17 g/L | 1.87 mg/L | Immunity transmission turbidity |
| Apolipoprotein B | 1.26 g/L | 1.29 mg/L | Immunity transmission turbidity |
| HDL sterol | 1.85 mmol/L | 1.62 mmol/L | Direct one-step method |
| Low-density lipoprotein sterol | 4.92 mmol/L | 4.79 mmol/L | Direct one-step method |
| LP(a) | 168.0 mg/L | 155.0 mg/L | Immunity transmission turbidity |
Have from the above-mentioned visible Synsepalum dulcuficum (Schum.) Daniell syrup of the invention of test result to reduction uric acid in blood, urea, triglycerides
There is obvious action, wherein uric acid and urea is even more to be reduced to normal level from improper level, and gout is prevented and treated to alleviation
With significant effect.
Embodiment described above is only presently preferred embodiments of the present invention, not does any formal limit to the present invention
System.Any those skilled in the art, without departing from the scope of the technical proposal of the invention, utilize the skill of the disclosure above
Art content makes more possible variations and retouching to technical solution of the present invention, or modification is accordingly to be regarded as the equivalence enforcement of equivalent variations
Example.Therefore all contents without departing from technical solution of the present invention, the equivalent equivalence changes that the thinking according to the present invention is made, it all should cover
In in protection scope of the present invention.
Claims (3)
1. one kind reduction uric acid prevents antipodagric Synsepalum dulcuficum (Schum.) Daniell syrup, it is characterised in that include the raw material of following parts by weight：Honey is drawn
Holy fruit 80-130 parts, 50-70 parts of rock sugar, 150-200 parts of Lemon fruit, 1-1.2 parts of Synsepalum dulcuficum (Schum.) Daniell leaf, 1-1.2 parts of lemonlike citrus leaf.
2. a kind of reduction uric acid as claimed in claim 1 prevents the preparation method of antipodagric Synsepalum dulcuficum (Schum.) Daniell syrup, its feature exists
In comprising the following steps：S1. Synsepalum dulcuficum (Schum.) Daniell, rock sugar, Lemon fruit, Synsepalum dulcuficum (Schum.) Daniell leaf and lemonlike citrus leaf are proportionally weighed；S2.
Synsepalum dulcuficum (Schum.) Daniell is enucleated, after Lemon fruit stoning peeling, Synsepalum dulcuficum (Schum.) Daniell, Lemon fruit, Synsepalum dulcuficum (Schum.) Daniell leaf, lemonlike citrus leaf and rock sugar entered
The broken the latter of row mixing crushes respectively, and most all raw material mixing at last；S3. mixed raw material will be crushed at 100-150 DEG C
At a temperature of boiling 5-15h, until the soft rotten formation syrup of raw material；S4. the syrup after boiling is cooled down, cool time is
2.5-3h；S5. the syrup after cooling is packaged.
3. reduction uric acid according to claim 2 prevents the preparation method of antipodagric Synsepalum dulcuficum (Schum.) Daniell syrup, it is characterised in that：
The type of cooling in the step S4 cools down for ice bath.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710287728.0A CN107156409A (en) | 2017-04-27 | 2017-04-27 | One kind reduction uric acid prevents antipodagric Synsepalum dulcuficum (Schum.) Daniell syrup and its production technology |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710287728.0A CN107156409A (en) | 2017-04-27 | 2017-04-27 | One kind reduction uric acid prevents antipodagric Synsepalum dulcuficum (Schum.) Daniell syrup and its production technology |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107156409A true CN107156409A (en) | 2017-09-15 |
Family
ID=59813701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710287728.0A Pending CN107156409A (en) | 2017-04-27 | 2017-04-27 | One kind reduction uric acid prevents antipodagric Synsepalum dulcuficum (Schum.) Daniell syrup and its production technology |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107156409A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108310093A (en) * | 2018-02-01 | 2018-07-24 | 张艳 | A kind of lemon slurry and preparation method thereof and application |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101156918A (en) * | 2007-10-10 | 2008-04-09 | 李志民 | A medicine for treating gout and preparation method |
| CN104432309A (en) * | 2014-11-13 | 2015-03-25 | 张�诚 | Beverage for relieving gout and preparation method |
| US20160151438A1 (en) * | 2008-04-28 | 2016-06-02 | Kent J. Truscott | Synergistic formulation for relieving gout symptoms |
-
2017
- 2017-04-27 CN CN201710287728.0A patent/CN107156409A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101156918A (en) * | 2007-10-10 | 2008-04-09 | 李志民 | A medicine for treating gout and preparation method |
| US20160151438A1 (en) * | 2008-04-28 | 2016-06-02 | Kent J. Truscott | Synergistic formulation for relieving gout symptoms |
| CN104432309A (en) * | 2014-11-13 | 2015-03-25 | 张�诚 | Beverage for relieving gout and preparation method |
Non-Patent Citations (2)
| Title |
|---|
| 王红静: "柠檬降尿酸效果研究", 《中国优秀硕士学位论文全文数据库（电子期刊）》 * |
| 陈宇勒: "《家养药食两用花草》", 31 July 2015, 福建科学出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108310093A (en) * | 2018-02-01 | 2018-07-24 | 张艳 | A kind of lemon slurry and preparation method thereof and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102318674B (en) | Preparation method of ginger tea juice active lactobacillary milk beverage | |
| US20060099277A1 (en) | Protein and fruit juice product | |
| CN103229834A (en) | Milk tea with tartary buckwheat and quinoa, and production method of milk tea | |
| CN101731659A (en) | Egg powder rich in organic selenium and low in cholesterol and production method thereof | |
| CN103141896B (en) | Heat-clearing and pathogenic-fire-reducing banana beverage | |
| CN111466444A (en) | Formula milk powder for promoting growth and development of children and preparation method thereof | |
| CN105285644B (en) | A kind of vinegar beverage rich in dietary fiber and preparation method thereof | |
| CN106889393A (en) | A kind of fructus cannabis drinks and preparation method thereof | |
| CN104286841A (en) | Total nutrient preparation for stroke patients | |
| CN102499311B (en) | Ice cream containing highland barley grains and preparation method thereof | |
| CN106213105A (en) | Medlar red date Fructus Nitraria schoberi compounds solid beverage and preparation method thereof | |
| CN107156409A (en) | One kind reduction uric acid prevents antipodagric Synsepalum dulcuficum (Schum.) Daniell syrup and its production technology | |
| CN105166901B (en) | A kind of dialysis patient alimentation composition | |
| CN101433284B (en) | Black rice milk beverage and preparation method thereof | |
| CN101703113A (en) | Method for processing sesame grease and protein food at low temperature | |
| CN108185364A (en) | A kind of fragrant citrus jam | |
| CN104382066A (en) | Sugar-free and high-fiber gelatin cake with function of enhancing replenishment of blood | |
| CN102894093B (en) | Novel sugar-free tartary buckwheat and walnut milk beverage and production method | |
| CN106858247A (en) | A kind of preparation method of brown rice, adlay sour milk beverage | |
| CN102499310B (en) | Ice cream containing highland barley granules and preparation method for ice cream | |
| CN106616099A (en) | Health-care beverage capable of improving appetite of children and preparation method thereof | |
| CN105936852A (en) | Cherry tea medicinal wine and making method thereof | |
| CN105876557A (en) | Radix Puerariae liver protecting beverage and preparation method thereof | |
| CN102266043A (en) | Novel production technology of nutrient health Rosa roxburghii solid beverage | |
| Patil | Health Benefits of Jaggery Tea on the Account of COVID-19 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170915 |
|
| RJ01 | Rejection of invention patent application after publication |